The BEXS 12 system enables automated extraction of DNA from 12 blood samples (250 μL each) or viral nucleic acids from various clinical samples, achieving high purity and yield.
DaraEx plus (CE-IVD)
DaraEx compound inhibits the agglutination effect of anti-CD38 in IAT without side effects.
DaraPC: 0.5 mg/ml anti-CD38 antibody
DaraEx compound inhibits the agglutination effect of anti-CD38 in IAT without side effects.
FluoGene®
FluoQube® data auto-imports into FluoGene® software for error-free analysis. Barcoded plates ensure sample tracking. Software aids interpretation, offers 4-eye validation, and LIMS-compatible export.
FluoQube
FluoQube® is a versatile system that integrates amplification and fluorescence reading, supporting FluoGene® kits and other real-time PCR protocols.
HLA FluoGene A
TaqMan® based typing of HLA-A alleles
HLA FluoGene ABC
TaqMan® based typing of HLA class I alleles
HLA FluoGene ABDR
TaqMan® based typing of HLA-A, -B, -DRB1, 3, 4 & 5 alleles
HLA FluoGene B
TaqMan® based typing of HLA-B alleles
HLA FluoGene B27
TaqMan® based typing of HLA-B*27 alleles associated with Morbus Bechterew
HLA FluoGene C
TaqMan® based typing of HLA-C alleles
HLA FluoGene DPB1
TaqMan® based typing of HLA-DPB1 alleles
HLA FluoGene DR
TaqMan® based typing of HLA-DRB1, 3, 4 & 5 alleles
HLA FluoGene DRDQ
TaqMan® based typing of HLA-DRB1, 3, 4, 5 & -DQB1 alleles
HLA FluoGene DRDQ plus
TaqMan® based typing of HLA-DRB1, 3, 4, 5, -DQA1 & -DQB1 alleles
HLA FluoGene384 Match
TaqMan® based typing of HLA-A, -B, -C, -DRB1, 3, 4 & 5, -DQA1, -DQB1, -DPA1 and -DPB1 alleles in SABR resolution. Detection of all 23 CWD null alleles as well as all
CIWD common and intermediate null alleles.
HLA FluoGeneNX ABCDRDQ
TaqMan® based typing of HLA-A, -B, -C, -DRB1, 3, 4 & 5, -DQA1 and -DQB1 alleles
HLA FluoGeneNX Match
qMan® based typing of HLA-A, -B, -C, -DRB1, 3, 4 & 5, -DQA1, -DQB1, -DPA1 and -DPB1 alleles in SABR resolution. Detection of all 23 CWD null alleles as well as all
CIWD common and intermediate null alleles.
HLA Ready Gene A
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene ABC
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene ABC+Taq
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene ABDR
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene ABDR+Taq
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene B
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene B27
HLA-Ready kits offer efficient gene disease screening via PCR, including controls and polymerase, ideal for exclusion diagnostics.
HLA Ready Gene B57
HLA-Ready kits offer efficient gene disease screening using few PCR reactions, including controls meeting international standards.
HLA Ready Gene Coeliac Disease
HLA-Ready kits efficiently screen patients for gene diseases using minimal PCR reactions, including controls meeting international standards.
HLA Ready Gene DPB1
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene DQ
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene DR
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene DRDQ
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA Ready Gene DRDQDP plus+Taq
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HLA-Ready Gene C
SSP-PCR, a classic technique, is easily implemented in any molecular biology lab with basic equipment.
HPA FluoGene
HPA-FluoGene® combines minimal hands-on time with reliable Real-time PCR.
HPA FluoGene 1 a/b Screen
HPA-FluoGene® combines minimal hands-on time with reliable Real-time PCR.
KIR Ready Gene
KIR receptors on NK cells detect and target pathological cells (tumors, infected cells) in the mammalian immune system.
NGStype®
NGStype® software rapidly analyzes Illumina NGS data, providing high-resolution typing results. Ambiguities are easily resolved with intuitive tools. Reports include allele information and heterozygosity ratios, exportable to LIMS.
RBC FluoGene ABO plus
RBC-FluoGene® ABO system distinguishes ABO*A1.01, ABO*A2.01, ABO*B.01, and ABO*O.01 alleles.
RBC FluoGene D® weak/variant
Weak D blood types have varying point mutations reducing Rh/D antigen, impacting agglutination. RBC FluoGene D detects most common weak D alleles and DEL alleles.
RBC FluoGene® ABO basic
RBC-FluoGene® ABO system distinguishes ABO*A1.01, ABO*A2.01, ABO*B.01, and ABO*O.01 alleles.
RBC FluoGene® CDE
This system detects RHCE alleles, RHD categories, hybrid genes, null alleles, and partial Ds using exon patterns and SNPs.
RBC FluoGene® CDE eXtend
CDE eXtend Kit expands CDE Kit, enabling comprehensive RHD/RHCE genotyping. It detects more weak D, DEL, and RHCE variants.
RBC FluoGene® D-Screen
A single test detects RHD exons 3, 5, and 10 in serologically negative donor samples.
RBC FluoGene® Rare
Current system detects rare blood group alleles for Diego, Wright, Cartwright, Lutheran, Kell, Colton, Knops, and Landsteiner-Wiener systems; each system has one common and one rare allele.
RBC FluoGene® vERYfy
This kit simultaneously tests multiple blood group systems (Rh, Kell, Kidd, Duffy, MNS, Dombrock), resolving ambiguities and identifying rare alleles, including those in polytransfused or antibody-positive patients.
RBC FluoGene® vERYfy eXtend
RBC-FluoGene® vERYfy eXtend performs comprehensive blood group typing (RHD/RHCE, KEL, JK, FY, MNS, DO, LU, YT, DI, CO, KN, LW) in a single test. See enclosed specificity tables for details.
Ready Gene Online
ReadyGene Online automates agarose gel analysis.
Recombinant Blood Group Antigen - Cartwright(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Cellano-Kpb-Jsa
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Chido(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - CROM/DAF
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Dombrock(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Indian(b)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - JMH
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Kell-Kpb-Jsa
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Knops(a)/DACY
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Landsteiner-Wiener(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Lutheran(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Lutheran(b)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Rodgers(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Scianna1
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - Xg(a)
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.
Recombinant Blood Group Antigen - YCAD
Recombinant blood group antigens (rBGA) improve blood transfusion safety by specifically inhibiting antibodies, resolving issues with antibody identification and preventing incompatible transfusions.